The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
Clinical trial NCT05813561 · COMPLETED
Trial details
- NCT number
- NCT05813561
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2022-07-23
- Enrollment
- 332
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.